Viewing Study NCT05006534


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-27 @ 10:39 AM
Study NCT ID: NCT05006534
Status: COMPLETED
Last Update Posted: 2021-08-16
First Post: 2021-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module